Quick Answer
AMGEN INC reported Net Income Loss of $7.71 billion for the year ending 2025.
- AMGEN INC showed an increase of +88.5% in Net Income Loss from 2024 to 2025.
- This data is from AMGEN INC's annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), AMGEN INC's Net Income Loss has grown by 90.3%.
- Historical annual values: Fiscal year 2025: $7.71 billion | Fiscal year 2024: $4.09 billion | Fiscal year 2023: $6.72 billion | Fiscal year 2022: $6.55 billion | Fiscal year 2021: $5.89 billion | Fiscal year 2020: $7.26 billion | Fiscal year 2019: $7.84 billion | Fiscal year 2018: $8.39 billion | Fiscal year 2017: $1.98 billion | Fiscal year 2016: $7.72 billion | Fiscal year 2015: $6.94 billion | Fiscal year 2014: $5.16 billion | Fiscal year 2013: $5.08 billion | Fiscal year 2012: $4.35 billion | Fiscal year 2011: $3.68 billion | Fiscal year 2010: $4.63 billion | Fiscal year 2009: $4.61 billion | Fiscal year 2008: $4.05 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: